XanthOmega TM Krill Oil
Natural health product licensed in Canada
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80045561
- Status
- Active licence
- Licence date
- 17 October 2013
- Revision date
- 16 January 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,3'-dihydroxy-4,4'-diketo-bêta-carotène Source : Haematococcus pluvialis - whole | 6 mg | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 22 mg Docosahexaenoic acid | 440 mg | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 40 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 176 mg Phospholipids | Not specified | Not calculated |
Non-medicinal ingredients
Gélatine, Glycérine, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Astaxanthin helps to improve physical endurance. Astaxanthin helps to reduce eyestrain and eye fatigue.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur with shellfish; if this occurs, discontinue use. Stomach/abdominal pain has been known to occur, in which case discontinue use (and consult a health care practitioner).
Source
Official Health Canada record, licence 80045561
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging